Depo-Provera (Injectable Contraceptive)—A Review

Dabancens A. Prado R. Larraguibel R. Zanartu J. (1974). Intraepithelial cervical neoplasia in women using intrauterine devices and long-acting injectable progestogens as contraceptives. American Journal of Obstetrics and Gynecology, 119, 1052.

Dodds G. (1971). Depo-Provera, a report on the clinical findings and two-year follow-up of 1,883 women treated by three-monthly injections of Depo-Provera. In: Hudono S. T. (ed). Proceedings of the Fifth Asian Congress of Obstetrics and Gynaecology, Djakarta, Indonesia, October 8–15, 1971.

El-Mahgoub S. E. Karim M. Ammar R. (1972). Long-term effects of injected progestogens on the morphology of human oviducts. Journal of Reproductive Medicine, 8, 288.

Ide P. Wijnants P. Bonte J. (1972). Observations cytologiques de frottis cervico-vaginaux sous contraception hormonal. (Cytological observations of cervico-vaginal smears under hormone contraception). Revue de Cytologie Clinique, 5, 105.

Koetsawang S. Srisupandit S. Srivanaboon S. Bhiraleus P. Rachawat D. Kiriwat O. Koetsawang A. (1974). Intramuscular depot-medroxypro-gesterone acetate for contraception. Journal of the Medical Association of Thailand, 57, 396.

McDaniel E. B. Pardthaisong T. (1971). Incidence of breast nodules and changes in breast size during prolonged use of DMPA injection for contraception. Paper presented at the annual meeting of the Medical Association of Thailand, Khon Kaen, Thailand, December 2–4, 1971.

McDaniel E. B. Pardthaisong T. (1973). Depot-medroxyprogesterone acetate as a contraceptive agent: return of fertility after discontinuation of use. Contraception, 8, 407.

Mishell D. R. Jr . (1967). Effect of 6α-methyl-17α-hydroxyprogesterone on urinary excretion of luteinizing hormone. American Journal of Obstetrics and Gynecology, 99, 86.

Mishell D. R. El-Habashy M. A. Good R. G. Moyer D. L. (1970). Contraception with an injectable progestin: study of its use in postpartum women. American Journal of Obstetrics and Gynecology, 101, 1046.

Rice-Wray E. Gutierrez J. Gorodovsky J. Maqueo M. Goldzieher J. W. (1974). Injectable contraceptives in family planning: clinical experience in 14, 958 cycles. Paper presented at annual meeting of the Family Planning Association of the Americans, Inc., Palm Springs, California, 1974.

Schwallie P. C. Assenzo J. R. (1974). The effect of depo-medroxy-progesterone acetate on pituitary and ovarian function and the return of fertility following discontinuation: a review. Contraception, 10, 181.

Schwallie P. C. Mohberg N. R. Assenso J. R. (1974). Review of cervical carcinoma in situ associated with the use of Depo-Provera. June 3 (unpublished).

Spellacy W. N. McLeod A. G. W. Buhi W. C. Birk S. A. McReary S. A. (1970). Medroxyprogesterone acetate and carbohydrate metabolism: measurement of glucose, insulin and growth hormone during 6 months time. Fertility and Sterility, 21, 457.

Vermeulen A. Thiery M. (1974). Hormonal contraceptives and carbohydrate tolerance. II. Influence of medroxyprogesterone acetate and chronic oral contraceptives. Diabetologia, 10, 253.

Wilson E. (1976). Use of long-acting depot progestogen in domiciliary family planning. British Medical Journal, 2, 1435.